Latest / 20-Minute Health Talk
Injectable PrEP: Adding choice to HIV prevention
An estimated 38,000 Americans are diagnosed with HIV annually. An important tool in the effort to end the ongoing epidemic is an injectable form of pre-exposure prophylaxis (PrEP), the first option to prevent HIV that does not involve taking a daily pill. The injectable form of the drug received FDA approval in late 2021 and has begun to hit the market. This is Part 2 of our conversation (Recorded May 16, 2022) with a panel of experts specializing in the HIV treatment and prevention. They discuss the benefits and what people at risk for HIV should know, challenges of implementation among…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.